FGF2 and head and neck squamous cell carcinoma: Given the relationship between FGF2 expression and ECs, and the low level of CAR expression on ECs in HNSCC, there may be a potential role for FGF2-targeted therapy as an additional therapeutic strategy of antiangiogenesis.